Just another angle - which prove to be absolutely wrong. Novosorb is proven to support the healing of burns and other wounds at the dermis level. Many people in hospitals (or requiring home care and key medical expertise) is for the treatment of recalcitrant wounds. Is there a chance to free up this expertise by accelerating wound repatriation via Novosorb?
I know this may be a stretch, (and looking for an upside here) however I do think most of the general public do not understand how recalcitrant and problematic wounds are. Is this a possible accelerant for uptake of Novosorb in order to free up beds/personnel/key resources?
Coronavirus Fears, page-3
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.040(1.91%) |
Mkt cap ! $1.418B | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.14 | $2.04 | $1.879M | 908.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4378 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.06 |
Change
-0.040 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.14 | $2.04 | 350187 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| PNV (ASX) Chart |